{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:54:56Z","timestamp":1777046096151,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T00:00:00Z","timestamp":1472515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 069350"],"award-info":[{"award-number":["DK 069350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 069350"],"award-info":[{"award-number":["DK 069350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK 069350"],"award-info":[{"award-number":["DK 069350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00198-016-3750-0","type":"journal-article","created":{"date-parts":[[2016,8,30]],"date-time":"2016-08-30T14:21:51Z","timestamp":1472566911000},"page":"463-471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Bone imaging in hypoparathyroidism"],"prefix":"10.1007","volume":"28","author":[{"given":"B. C.","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. E.","family":"Cusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,30]]},"reference":[{"key":"3750_CR1","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, et al. (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26:2317\u20132337","journal-title":"J Bone Miner Res"},{"key":"3750_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"Shoback D (2008) Clinical practice. Hypoparathyroidism. N Engl J Med 359:391\u2013403","journal-title":"N Engl J Med"},{"issue":"European Societ","key":"3750_CR3","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","volume":"173","author":"J Bollerslev","year":"2015","unstructured":"Bollerslev J, Rejnmark L, Marcocci C, Shoback DM, Sitges-Serra A, van Biesen W, Dekkers OM (2015) European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults. Eur J Endocrinol 173(European Society of E):G1\u201320","journal-title":"Eur J Endocrinol"},{"key":"3750_CR4","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H (2013) Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 28:2570\u20132576","journal-title":"J Bone Miner Res"},{"key":"3750_CR5","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28:2277\u20132285","journal-title":"J Bone Miner Res"},{"key":"3750_CR6","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 30:1738\u20131744","journal-title":"J Bone Miner Res"},{"key":"3750_CR7","doi-asserted-by":"crossref","unstructured":"Cating-Cabral M, Clarke B (2015) Epidemiology of hypoparathyroidism. In: Bilezikian J (ed) The parathyroids, 3rd edn. Elsevier Inc., p 707\u2013717","DOI":"10.1016\/B978-0-12-397166-1.00049-7"},{"key":"3750_CR8","unstructured":"Silva B, Kousteni S (2015) Cellular actions of PTH: osteoblasts, osteoclasts, and osteocytes. In: Bilezikian J (ed) The parathyroids, 3rd edn. Elsevier Inc., p 127\u2013137"},{"key":"3750_CR9","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1210\/jc.2012-1808","volume":"97","author":"DM Mitchell","year":"2012","unstructured":"Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M (2012) Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab 97:4507\u20134514","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2265.2006.02479.x","volume":"64","author":"BA Laway","year":"2006","unstructured":"Laway BA, Goswami R, Singh N, Gupta N, Seith A (2006) Pattern of bone mineral density in patients with sporadic idiopathic hypoparathyroidism. Clin Endocrinol 64:405\u2013409","journal-title":"Clin Endocrinol"},{"key":"3750_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","volume":"18","author":"BL Langdahl","year":"1996","unstructured":"Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P (1996) Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 18:103\u2013108","journal-title":"Bone"},{"key":"3750_CR12","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr, Silverberg SJ, Bilezikian JP (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23:2018\u20132024","journal-title":"J Bone Miner Res"},{"key":"3750_CR13","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jbmr.452","volume":"26","author":"MR Rubin","year":"2011","unstructured":"Rubin MR, Dempster DW, Sliney J Jr, et al. (2011) PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res 26:2727\u20132736","journal-title":"J Bone Miner Res"},{"key":"3750_CR14","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1590\/0004-2730000003399","volume":"58","author":"BL Clarke","year":"2014","unstructured":"Clarke BL (2014) Bone disease in hypoparathyroidism. Arq Bras Endocrinol Metabol 58:545\u2013552","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"3750_CR15","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jbmr.2609","volume":"31","author":"NE Cusano","year":"2016","unstructured":"Cusano NE, Nishiyama KK, Zhang C, Rubin MR, Boutroy S, McMahon DJ, Guo XE, Bilezikian JP (2016) Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism. J Bone Miner Res 31:308\u2013316","journal-title":"J Bone Miner Res"},{"key":"3750_CR16","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","volume":"29","author":"L Underbjerg","year":"2014","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2014) Postsurgical hypoparathyroidism\u2014risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res 29:2504\u20132510","journal-title":"J Bone Miner Res"},{"key":"3750_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.beem.2014.09.001","volume":"29","author":"NE Cusano","year":"2015","unstructured":"Cusano NE, Rubin MR, Bilezikian JP (2015) Parathyroid hormone therapy for hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 29:47\u201355","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3750_CR18","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00198-012-2230-4","volume":"24","author":"L Rejnmark","year":"2013","unstructured":"Rejnmark L, Sikjaer T, Underbjerg L, Mosekilde L (2013) PTH replacement therapy of hypoparathyroidism. Osteoporos Int 24:1529\u20131536","journal-title":"Osteoporos Int"},{"key":"3750_CR19","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/jbmr.2777","volume":"31","author":"MR Rubin","year":"2016","unstructured":"Rubin MR, Zwahlen A, Dempster DW, Zhou H, Cusano NE, Zhang C, Muller R, Bilezikian JP (2016) Effects of parathyroid hormone administration on bone strength in hypoparathyroidism. J Bone Miner Res 31:1082\u20131088","journal-title":"J Bone Miner Res"},{"key":"3750_CR20","first-page":"1617","volume":"76","author":"S Abugassa","year":"1993","unstructured":"Abugassa S, Nordenstrom J, Eriksson S, Sjoden G (1993) Bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 76:1617\u20131621","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR21","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1210\/jc.2002-021388","volume":"88","author":"FK Chan","year":"2003","unstructured":"Chan FK, Tiu SC, Choi KL, Choi CH, Kong AP, Shek CC (2003) Increased bone mineral density in patients with chronic hypoparathyroidism. J Clin Endocrinol Metab 88:3155\u20133159","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR22","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1210\/jc.2003-030470","volume":"88","author":"Q Chen","year":"2003","unstructured":"Chen Q, Kaji H, MF I, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K (2003) Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 88:4655\u20134658","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR23","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L (2011) The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res 26:2358\u20132370","journal-title":"J Bone Miner Res"},{"key":"3750_CR24","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1007\/s00268-013-2207-2","volume":"37","author":"Y Takamura","year":"2013","unstructured":"Takamura Y, Miyauchi A, Yabuta T, Kihara M, Ito Y, Miya A (2013) Attenuation of postmenopausal bone loss in patients with transient hypoparathyroidism after total thyroidectomy. World J Surg 37:2860\u20132865","journal-title":"World J Surg"},{"key":"3750_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1210\/jc.2012-2984","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Rubin MR, McMahon DJ, Zhang C, Ives R, Tulley A, Sliney J Jr, Cremers SC, Bilezikian JP (2013) Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety. J Clin Endocrinol Metab 98:137\u2013144","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR26","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","volume":"21","author":"MR Rubin","year":"2010","unstructured":"Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP (2010) Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int 21:1927\u20131934","journal-title":"Osteoporos Int"},{"key":"3750_CR27","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","volume":"88","author":"KK Winer","year":"2003","unstructured":"Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D, Gerber LH, McGarvey C, Cutler GB Jr (2003) Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88:4214\u20134220","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR28","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jbmr.1627","volume":"27","author":"RI Gafni","year":"2012","unstructured":"Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT (2012) Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811\u20131820","journal-title":"J Bone Miner Res"},{"key":"3750_CR29","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1210\/jc.2009-2464","volume":"95","author":"KK Winer","year":"2010","unstructured":"Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr (2010) Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab 95:2680\u20132688","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR30","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/jbmr.2555","volume":"30","author":"RI Gafni","year":"2015","unstructured":"Gafni RI, Guthrie LC, Kelly MH, Brillante BA, Christie CM, Reynolds JC, Yovetich NA, James R, Collins MT (2015) Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1-34 (hPTH 1-34) replacement therapy in hypoparathyroidism. J Bone Miner Res 30:2112\u20132118","journal-title":"J Bone Miner Res"},{"key":"3750_CR31","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/jbmr.2176","volume":"29","author":"BC Silva","year":"2014","unstructured":"Silva BC, Leslie WD, Resch H, Lamy O, Lesnyak O, Binkley N, McCloskey EV, Kanis JA, Bilezikian JP (2014) Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 29:518\u2013530","journal-title":"J Bone Miner Res"},{"key":"3750_CR32","doi-asserted-by":"crossref","unstructured":"McCloskey EV, Oden A, Harvey NC, et al. (2016) A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 31:940\u2013948","DOI":"10.1002\/jbmr.2734"},{"key":"3750_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jocd.2015.06.008","volume":"18","author":"BC Silva","year":"2015","unstructured":"Silva BC, Broy SB, Boutroy S, Schousboe JT, Shepherd JA, Leslie WD (2015) Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD official positions part 2: trabecular bone score. J Clin Densitom 18:309\u2013330","journal-title":"J Clin Densitom"},{"key":"3750_CR34","unstructured":"Silva B, Cusano, NE, Zhang, C, et al. (2013) Beneficial effects of PTH(1-84) in hypoparathyroidism as determined by microarchitectural texture assessment (TBS): a 4-year experience. ASBMR 2013 Annual Meeting Abstract"},{"key":"3750_CR35","unstructured":"Cipriani C, Silva B, Cusano N, et al. (2014) Beneficial effects of PTH(1-84) in hypoparathyroidism as determined by trabecular bone score (TBS). ASBMR 2014 Annual Meeting Abstract"},{"key":"3750_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","volume":"46","author":"MR Rubin","year":"2010","unstructured":"Rubin MR, Dempster DW, Kohler T, et al. (2010) Three dimensional cancellous bone structure in hypoparathyroidism. Bone 46:190\u2013195","journal-title":"Bone"},{"key":"3750_CR37","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.bone.2011.07.037","volume":"49","author":"S Boutroy","year":"2011","unstructured":"Boutroy S, Vilayphiou N, Roux JP, Delmas PD, Blain H, Chapurlat RD, Chavassieux P (2011) Comparison of 2D and 3D bone microarchitecture evaluation at the femoral neck, among postmenopausal women with hip fracture or hip osteoarthritis. Bone 49:1055\u20131061","journal-title":"Bone"},{"key":"3750_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","volume":"21","author":"A Cohen","year":"2010","unstructured":"Cohen A, Dempster DW, Muller R, et al. (2010) Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: comparison with transiliac bone biopsy. Osteoporos Int 21:263\u2013273","journal-title":"Osteoporos Int"},{"key":"3750_CR39","unstructured":"Cusano N, Rubin R, Silva B, Zhang C, Fan W, Romano M, Anderson L, Sliney Jr J, Bilezikian JP (2013) Parathyroid hormone regulates bone microstructure: reciprocal changes after treatment of hyper and hypoparathyroid subjects. ASBMR 2013 Annual Meeting Abstract"},{"key":"3750_CR40","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jbmr.1493","volume":"27","author":"T Sikjaer","year":"2012","unstructured":"Sikjaer T, Rejnmark L, Thomsen JS, Tietze A, Bruel A, Andersen G, Mosekilde L (2012) Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res 27:781\u2013788","journal-title":"J Bone Miner Res"},{"key":"3750_CR41","unstructured":"Boutroy S, Rubin MR, Cusano NE, Costa AG, Lenane Z, Sliney Jr J, Bilezikian JP (2012) Four-year effects of PTH(1\u201384) on cortical bone in hypoparathyroidism. ASBMR 2012 Annual Meeting Abstract"},{"key":"3750_CR42","first-page":"2135","volume":"80","author":"K Fujiyama","year":"1995","unstructured":"Fujiyama K, Kiriyama T, Ito M, Nakata K, Yamashita S, Yokoyama N, Nagataki S (1995) Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism. J Clin Endocrinol Metab 80:2135\u20132138","journal-title":"J Clin Endocrinol Metab"},{"key":"3750_CR43","doi-asserted-by":"crossref","unstructured":"Mendonca ML, Pereira FA, Nogueira-Barbosa MH, Monsignore LM, Teixeira SR, Watanabe PC, Maciel LM, de Paula FJ (2013) Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr Disord 13:1","DOI":"10.1186\/1472-6823-13-1"},{"key":"3750_CR44","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","volume":"101","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, Rubin MR, Winer KK, Liberman UA, Potts JT Jr (2016) Management of hypoparathyroidism: present and future. J Clin Endocrinol Metab 101:2313\u20132324","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3750-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3750-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3750-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3750-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T03:50:26Z","timestamp":1718769026000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3750-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,30]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["3750"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3750-0","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,30]]},"assertion":[{"value":"22 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Barbara Silva and Natalie Cusano declare that they have no conflict of interest.Mishaela Rubin: Shire Pharmaceuticals (research grant).John Bilezikian: Merck, Amgen, Radius (consultant); Shire Pharmaceuticals (research grant).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}